Form 4: MaxCyte General Counsel David Sandoval Reports Sale of Shares to Cover Tax Withholdings
SEC Form 4 Filing
David Sandoval, General Counsel of MaxCyte, Inc., reports the sale of 353 shares of common stock to cover tax withholding obligations upon the vesting of restricted stock units.
Summary
- On March 18, 2025, David Sandoval, General Counsel of MaxCyte, Inc., sold 353 shares of common stock.
- The sale was executed to cover tax withholding obligations related to the vesting of previously granted restricted stock units (RSUs).
- The shares were sold at a weighted average price of $3.1793.
- Following the transaction, Sandoval beneficially owns 64,219 shares of MaxCyte common stock.
Sentiment
Score: 5
Explanation: The Form 4 filing represents a routine transaction related to tax obligations and does not inherently indicate positive or negative sentiment. It's a neutral event.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of a change in sentiment regarding the company's prospects.
Stakeholder Impact
- The sale of shares has a minimal impact on shareholders as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of transaction: Sale of common stock. |
| 03/20/2025 | Date of signature on the Form 4 filing. |
Keywords
MaxCyte, MXCT, Form 4, David Sandoval, General Counsel, Stock Sale, Tax Withholding, RSUs, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.